Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-20

Clinical Trial Update: COMPARISON OF A COSMETIC SERUM AND 4% HYDROQUINONE FOR TREATING MELASMA OVER 84 DAYS [NA]

View source ↗

Summary

This clinical trial compares a cosmetic serum to 4% hydroquinone for treating facial melasma over 84 days and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cosmetic serum
  • Hydroquinone 4% (hydroquinone)

Snippet

Sponsor: Laboratoire Dermatologique ACM | Conditions: Healthy, Melasma (Facial Melasma) | NA | Status: RECRUITING